Skip to content
Triangle logo TriangleGet started
← Full study record

NCT05105087 · OUTCOME

Presence of Metastatic Deposits in the Sentinel Lymph Node (SLNs)

Gynecological Sentinel Lymph Nodes CEUS · Source last updated 2025-08-22

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
Metastatic sentinel lymph nodes (SLNs)
Interval / dispersion
Not reported
Time frame
Within 7 days post-surgery

What was measured

The presence or absence of metastatic deposits in SLNs will be obtained by pathology (when available).

Analysis population: Only participants who completed CEUS and surgery (N=5) were analyzed.

Groups in this outcome

Diagnostic (Perflubutane Microbubble, Ultrasound)

Patients receive perflubutane microbubble injections subdermally and then undergo ultrasound over 30 minutes before standard of care cancer treatment. Perflubutane Microbubble: Given subdermally Contrast-Enhanced Ultrasound: Undergo ultrasound

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Diagnostic (Perflubutane Microbubble, Ultrasound)5

Analysis denominator · sentinel lymph nodes (SLNs)

GroupSource count
Diagnostic (Perflubutane Microbubble, Ultrasound)11

Reported measurements

Source class 1
Values in Metastatic sentinel lymph nodes (SLNs) · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Diagnostic (Perflubutane Microbubble, Ultrasound)3Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        3
denom Units Selected
sentinel lymph nodes (SLNs)
denoms
  1. counts
    1. group Id
      OG000
      value
      5
    units
    Participants
  2. counts
    1. group Id
      OG000
      value
      11
    units
    sentinel lymph nodes (SLNs)
description
The presence or absence of metastatic deposits in SLNs will be obtained by pathology (when available).
groups
  1. description
    Patients receive perflubutane microbubble injections subdermally and then undergo ultrasound over 30 minutes before standard of care cancer treatment. Perflubutane Microbubble: Given subdermally Contrast-Enhanced Ultrasound: Undergo ultrasound
    id
    OG000
    title
    Diagnostic (Perflubutane Microbubble, Ultrasound)
param Type
NUMBER
population Description
Only participants who completed CEUS and surgery (N=5) were analyzed.
reporting Status
POSTED
time Frame
Within 7 days post-surgery
title
Presence of Metastatic Deposits in the Sentinel Lymph Node (SLNs)
type
SECONDARY
type Units Analyzed
sentinel lymph nodes (SLNs)
unit Of Measure
Metastatic sentinel lymph nodes (SLNs)

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice